Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity
Open Access
- 19 March 2021
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 6 (1) , 1-14
Abstract
Coxiella burnetiiis the bacterial causative agent of the zoonosis Q fever. The current human Q fever vaccine, Q-VAX®, is a fixed, whole cell vaccine (WCV) licensed solely for use in Australia.C. burnetiiWCV administration is associated with a dermal hypersensitivity reaction in people with pre-existing immunity toC. burnetii, limiting wider use. Consequently, a less reactogenic vaccine is needed. Here, we investigated contributions of theC. burnetiiDot/Icm type IVB secretion system (T4BSS) and lipopolysaccharide (LPS) in protection and reactogenicity of fixed WCVs. A 32.5 kb region containing 23dot/icmgenes was deleted in the virulent Nine Mile phase I (NMI) strain and the resulting mutant was evaluated in guinea pig models ofC. burnetiiinfection, vaccination-challenge, and post-vaccination hypersensitivity. The NMI ∆dot/icmstrain was avirulent, protective as a WCV against a robustC. burnetiichallenge, and displayed potentially altered reactogenicity compared to NMI. Nine Mile phase II (NMII) strains ofC. burnetiithat produce rough LPS, were similarly tested. NMI was significantly more protective than NMII as a WCV; however, both vaccines exhibited similar reactogenicity. Collectively, our results indicate that, like phase I LPS, the T4BSS is required for full virulence byC. burnetii. Conversely, unlike phase I LPS, the T4BSS is not required for vaccine-induced protection. LPS length does not appear to contribute to reactogenicity while the T4BSS may contribute to this response. NMI ∆dot/icmrepresents an avirulent phase I strain with full vaccine efficacy, illustrating the potential of genetically modifiedC. burnetiias improved WCVs.Keywords
This publication has 79 references indexed in Scilit:
- Two Systems for Targeted Gene Deletion in Coxiella burnetiiApplied and Environmental Microbiology, 2012
- Dot/Icm Type IVB Secretion System Requirements for Coxiella burnetii Growth in Human MacrophagesmBio, 2011
- Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth MediumApplied and Environmental Microbiology, 2011
- The Coxiella burnetii Dot/Icm System Delivers a Unique Repertoire of Type IV Effectors into Host Cells and Is Required for Intracellular ReplicationPLOS Pathogens, 2011
- Role of CD4+and CD8+T Cells in Clearance of Primary Pulmonary Infection withCoxiella burnetiiInfection and Immunity, 2010
- Coxiella burnetiiIsolates Cause Genogroup-Specific Virulence in Mouse and Guinea Pig Models of Acute Q FeverInfection and Immunity, 2009
- Comparative Genomics Reveal Extensive Transposon-Mediated Genomic Plasticity and Diversity among Potential Effector Proteins within the GenusCoxiellaInfection and Immunity, 2009
- Coxiella type IV secretion and cellular microbiologyCurrent Opinion in Microbiology, 2009
- Adaptive immunity to the obligate intracellular pathogen Coxiella burnetiiImmunologic Research, 2008
- Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q FeverInfection and Immunity, 2006